Jason Aryeh
Board Member
Orchestra BioMed Holdings, Inc. (OBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jason Aryeh
Jason Aryeh is recorded as Board Member at Orchestra BioMed Holdings, Inc. (OBIO). Jason Aryeh was last confirmed as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR) in a filing dated September 23, 2024. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed June 5, 2026 that Jason Aryeh was appointed Series A Preferred Director, effective June 4, 2026. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed August 21, 2024 that Jason Aryeh was appointed director, effective August 15, 2024. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed July 1, 2024 that Jason Aryeh was appointed Series A Board designee. Equibles holds 5 filed executive changes naming Jason Aryeh; each is listed under recent activity with its source filing.
“As a result of the foregoing voting results, each of the foregoing directors was elected to the Board of Directors of the Company to serve for a term expiring at the 2027 Annual Meeting and until their successors are duly elected and qualified, with seven such nominees elected by holders of Common Stock and holders of the Series A Preferred Stock, voting together as a single class, and the Series A Preferred Directors elected solely by holders of the Series A Preferred Stock.”
“On August 15, 2024, in accordance with the terms of the cooperation agreements between the Company and certain stockholders of the Company, which were previously disclosed on that certain Current Report on Form 8-K filed by the Company on July 1, 2024 (the “Cooperation Agreements”), the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors of the Board, effective immediately following the Annual Meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
-
2024-01-01–2024-09-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Orchestra BioMed Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- David Hochman CEO, Board Member
- David P. Hochman CEO, Board Member
- Andrew L. Taylor CFO
- Andrew Taylor CFO
- Michael D. Kaswan CFO
- Darren R. Sherman COO, Board Member
- Yuval Mika CTO
- Yuval Mika, Ph.D. CTO
- Chris Cleary Board Member
- Continuing Directors Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.